| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10001307 | HBV | ENSG00000183454.19 | protein_coding | GRIN2A | No | Yes | 2903 | Q12879 |
| TVIS10024003 | HBV | ENSG00000183454.19 | protein_coding | GRIN2A | No | Yes | 2903 | Q12879 |
| TVIS10027487 | HBV | ENSG00000183454.19 | protein_coding | GRIN2A | No | Yes | 2903 | Q12879 |
| TVIS10027488 | HBV | ENSG00000183454.19 | protein_coding | GRIN2A | No | Yes | 2903 | Q12879 |
| TVIS10021181 | HBV | ENSG00000183454.19 | protein_coding | GRIN2A | No | Yes | 2903 | Q12879 |
| TVIS10016445 | HBV | ENSG00000183454.19 | protein_coding | GRIN2A | No | Yes | 2903 | Q12879 |
| TVIS10052059 | HBV | ENSG00000183454.19 | protein_coding | GRIN2A | No | Yes | 2903 | Q12879 |
| TVIS10062493 | HBV | ENSG00000183454.19 | protein_coding | GRIN2A | No | Yes | 2903 | Q12879 |
| TVIS30006759 | HIV | ENSG00000183454.19 | protein_coding | GRIN2A | No | Yes | 2903 | Q12879 |
| TVIS30082985 | HIV | ENSG00000183454.19 | protein_coding | GRIN2A | No | Yes | 2903 | Q12879 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GRIN2A |
|---|---|
| DrugBank ID | DB00145 |
| Drug Name | Glycine |
| Target ID | BE0000760 |
| UniProt ID | Q12879 |
| Regulation Type | antagonist |
| PubMed IDs | 17360906; 17403555; 17513636; 17646495; 17405869; 11752352 |
| Citations | Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT: NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci. 2007 Mar 14;27(11):2846-57.@@Domingues A, Almeida S, da Cruz e Silva EF, Oliveira CR, Rego AC: Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits. Neurochem Int. 2007 May;50(6):872-80. Epub 2007 Mar 7.@@Brosnan RJ, Yang L, Milutinovic PS, Zhao J, Laster MJ, Eger EI 2nd, Sonner JM: Ammonia has anesthetic properties. Anesth Analg. 2007 Jun;104(6):1430-3, table of contents.@@Milutinovic PS, Yang L, Cantor RS, Eger EI 2nd, Sonner JM: Anesthetic-like modulation of a gamma-aminobutyric acid type A, strychnine-sensitive glycine, and N-methyl-d-aspartate receptors by coreleased neurotransmitters. Anesth Analg. 2007 Aug;105(2):386-92.@@Gabra BH, Kessler FK, Ritter JK, Dewey WL, Smith FL: Decrease in N-methyl-D-aspartic acid receptor-NR2B subunit levels by intrathecal short-hairpin RNA blocks group I metabotropic glutamate receptor-mediated hyperalgesia. J Pharmacol Exp Ther. 2007 Jul;322(1):186-94. Epub 2007 Apr 3.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. |
| Groups | Approved; Nutraceutical; Vet_approved |
| Direct Classification | Alpha amino acids |
| SMILES | NCC(O)=O |
| Pathways | gamma-Glutamyltranspeptidase Deficiency; Lesch-Nyhan Syndrome (LNS); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Molybdenum Cofactor Deficiency; AICA-Ribosiduria; Purine Nucleoside Phosphorylase Deficiency; gamma-Glutamyltransferase Deficiency; Hyperprolinemia Type II; Glutamate Metabolism; Adenine Phosphoribosyltransferase Deficiency (APRT); Mercaptopurine Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); L-Arginine:Glycine Amidinotransferase Deficiency; Hyperinsulinism-Hyperammonemia Syndrome; Congenital Bile Acid Synthesis Defect Type II; Porphyrin Metabolism; Prolidase Deficiency (PD); Glycine and Serine Metabolism; Carnitine Synthesis; Adenosine Deaminase Deficiency; Methionine Metabolism; Bile Acid Biosynthesis; Hyperprolinemia Type I; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; 27-Hydroxylase Deficiency; Sarcosine Oncometabolite Pathway; Purine Metabolism; Gout or Kelley-Seegmiller Syndrome; Ammonia Recycling |
| PharmGKB | PA449789 |
| ChEMBL | CHEMBL773 |